Figure 3From: No effect of epoprostenol on right ventricular diameter in patients with acute pulmonary embolism: a randomized controlled trial Mean (± SD) systolic PAP for both treatment groups at baseline, 2.5 and 24 hours after initiation of treatment and 48 hours after treatment was stopped (measurement 1, 2, 3 and 4 respectively).Back to article page